160 related articles for article (PubMed ID: 34631548)
1. Bortezomib Inhibits Multiple Myeloma Cells by Transactivating ATF3 to Trigger miR-135a-5p- Dependent Apoptosis.
Lai X; Huang C; Nie X; Chen Q; Tang Y; Fu X; Lin Y; Nie C; Xu X; Wang X; Chen R; Chen Z
Front Oncol; 2021; 11():720261. PubMed ID: 34631548
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-1252-5p Associated with Extracellular Vesicles Enhances Bortezomib Sensitivity in Multiple Myeloma Cells by Targeting Heparanase.
Rodrigues-Junior DM; Pelarin MFA; Nader HB; Vettore AL; Pinhal MAS
Onco Targets Ther; 2021; 14():455-467. PubMed ID: 33488100
[TBL] [Abstract][Full Text] [Related]
3. Lower expression of activating transcription factors 3 and 4 correlates with shorter progression-free survival in multiple myeloma patients receiving bortezomib plus dexamethasone therapy.
Narita T; Ri M; Masaki A; Mori F; Ito A; Kusumoto S; Ishida T; Komatsu H; Iida S
Blood Cancer J; 2015 Dec; 5(12):e373. PubMed ID: 26636288
[TBL] [Abstract][Full Text] [Related]
4. hsa-miR-631 resensitizes bortezomib-resistant multiple myeloma cell lines by inhibiting UbcH10.
Xi H; Li L; Du J; An R; Fan R; Lu J; Wu YX; Wu SX; Hou J; Zhao LM
Oncol Rep; 2017 Feb; 37(2):961-968. PubMed ID: 28000886
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of CCL2 via ATF3/c-Jun interaction mediated the Bortezomib-induced peripheral neuropathy.
Liu C; Luan S; OuYang H; Huang Z; Wu S; Ma C; Wei J; Xin W
Brain Behav Immun; 2016 Mar; 53():96-104. PubMed ID: 26554515
[TBL] [Abstract][Full Text] [Related]
6. CircRNA ITCH increases bortezomib sensitivity through regulating the miR-615-3p/PRKCD axis in multiple myeloma.
Liu J; Du F; Chen C; Li D; Chen Y; Xiao X; Hou X
Life Sci; 2020 Dec; 262():118506. PubMed ID: 33031827
[TBL] [Abstract][Full Text] [Related]
7. PKCδ regulates death receptor 5 expression induced by PS-341 through ATF4-ATF3/CHOP axis in human lung cancer cells.
Xu L; Su L; Liu X
Mol Cancer Ther; 2012 Oct; 11(10):2174-82. PubMed ID: 22848091
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of MBNL1-AS1 contributes to tumorigenesis of NSCLC via sponging miR-135a-5p.
Cao G; Tan B; Wei S; Shen W; Wang X; Chu Y; Rong T; Gao C
Biomed Pharmacother; 2020 May; 125():109856. PubMed ID: 32092823
[TBL] [Abstract][Full Text] [Related]
9. The Association of Neuronal Stress with Activating Transcription Factor 3 in Dorsal Root Ganglion of in vivo and in vitro Models of Bortezomib- Induced Neuropathy.
Yin Y; Qi X; Qiao Y; Liu H; Yan Z; Li H; Liu Z
Curr Cancer Drug Targets; 2019; 19(1):50-64. PubMed ID: 30289077
[TBL] [Abstract][Full Text] [Related]
10. Circ_0001742 promotes tongue squamous cell carcinoma progression via miR-431-5p/ATF3 axis.
Hu YT; Li XX; Zeng LW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10300-10312. PubMed ID: 31841185
[TBL] [Abstract][Full Text] [Related]
11. Molecular expression and functional analysis of genes in children with temporal lobe epilepsy.
Wu X; Wang Y; Sun Z; Ren S; Yang W; Deng Y; Tian C; Yu Y; Gao B
J Integr Neurosci; 2019 Mar; 18(1):71-77. PubMed ID: 31091851
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
Wei X; Yang X; Wang B; Yang Y; Fang Z; Yi C; Shi L; Song D
Cancer Med; 2020 Jan; 9(2):724-736. PubMed ID: 31769229
[TBL] [Abstract][Full Text] [Related]
13. Effect and mechanism of miR-135a-5p/CXCL12/JAK-STAT axis on inflammatory response after myocardial infarction.
Guo XY; Liu QL; Liu W; Cheng JX; Li ZJ
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12912-12928. PubMed ID: 33378042
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of lysyl oxidase-like 4 LOXL4 by miR-135a-5p promotes lung cancer progression in vitro and in vivo.
Zhang Y; Jiang WL; Yang JY; Huang J; Kang G; Hu HB; Xie S
J Cell Physiol; 2019 Aug; 234(10):18679-18687. PubMed ID: 30993701
[TBL] [Abstract][Full Text] [Related]
15. MiR-135a-5p modulates biological functions of thyroid carcinoma cells via targeting VCAN 3'-UTR.
Zhao X; Sun Z; Li H; Jiang F; Zhou J; Zhang L
Cancer Biomark; 2017 Aug; 20(2):207-216. PubMed ID: 28869452
[TBL] [Abstract][Full Text] [Related]
16. miR-135a-5p inhibitor protects glial cells against apoptosis via targeting SIRT1 in epilepsy.
Wang Y; Yang Z; Zhang K; Wan Y; Zhou Y; Yang Z
Exp Ther Med; 2021 May; 21(5):431. PubMed ID: 33747170
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of miR-135a-5p promotes the development of rat pulmonary arterial hypertension in vivo and in vitro.
Liu HM; Jia Y; Zhang YX; Yan J; Liao N; Li XH; Tang Y
Acta Pharmacol Sin; 2019 Apr; 40(4):477-485. PubMed ID: 30038339
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Hypertension by Modulating the Hsa-miR-124-3p/Nuclear Receptor Subfamily 3, Group C, Member 2 (NR3C2) and Hsa-miR-135a-5p/NR3C2 Axis.
Luo L; Wang Y; Hu P; Wu J
Med Sci Monit; 2020 Mar; 26():e920478. PubMed ID: 32222724
[TBL] [Abstract][Full Text] [Related]
19. LncRNA PRAL is closely related to clinical prognosis of multiple myeloma and the bortezomib sensitivity.
Xiao G; Li Y; Wang Y; Zhao B; Zou Z; Hou S; Jia X; Liu X; Yao Y; Wan J; Xiong H
Exp Cell Res; 2018 Sep; 370(2):254-263. PubMed ID: 29944867
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV alleviates atherosclerosis through targeting circ_0000231/miR-135a-5p/CLIC4 axis in AS cell model in vitro.
Shao X; Liu Z; Liu S; Lin N; Deng Y
Mol Cell Biochem; 2021 Apr; 476(4):1783-1795. PubMed ID: 33439448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
